DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 4, Pages e35857
Publisher
Public Library of Science (PLoS)
Online
2012-04-21
DOI
10.1371/journal.pone.0035857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee
- (2011) M. Preusser et al. CLINICAL NEUROPATHOLOGY
- A multigene predictor of outcome in glioblastoma
- (2011) H. Colman et al. NEURO-ONCOLOGY
- Molecular imaging of gliomas with PET: Opportunities and limitations
- (2011) C. la Fougere et al. NEURO-ONCOLOGY
- Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
- (2011) Kenneth L. Pitter et al. PLoS One
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Evaluation of Treatment-Associated Inflammatory Response on Diffusion-Weighted Magnetic Resonance Imaging and 2-[18F]-Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography Imaging Biomarkers
- (2010) C. J. Galban et al. CLINICAL CANCER RESEARCH
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
- (2010) Benjamin M. Ellingson et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1-13C]pyruvate and 13C magnetic resonance spectroscopic imaging
- (2010) Sam E. Day et al. MAGNETIC RESONANCE IN MEDICINE
- Molecular Pathogenesis of Malignant Glial Tumors
- (2010) Terreia S. Jones et al. TOXICOLOGIC PATHOLOGY
- Mouse models of CNS embryonal tumors
- (2009) Hiroyuki Momota et al. Brain Tumor Pathology
- Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
- (2009) Giulio Metro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Quantitative imaging biomarkers in neuro-oncology
- (2009) Adam D. Waldman et al. Nature Reviews Clinical Oncology
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Diffusion Imaging for Therapy Response Assessment of Brain Tumor
- (2009) Thomas L. Chenevert et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
- (2008) J. Sigmond et al. ANNALS OF ONCOLOGY
- Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival
- (2008) Daniel A. Hamstra et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas
- (2008) Oliver Dudeck et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started